Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03241485 · ClinicalTrials.gov registry record · Phase 4
Trial Comparing Intrathecal Morphine With Placebo In Patients Undergoing Robotic Cardiac Surgery
A Phase 4 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 79
- Enrollment target
NCT03241485 is a Phase 4 study that has completed, run by University of Chicago. The registered enrollment target is 79 participants.
The verdict
NCT03241485, a Phase 4 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 79 participants
- Enrollment target
Study Summary
This is a randomized clinical trial in patients undergoing robotic myocardial revascularization with intraoperative extubation. Patients will be randomized into placebo or intrathecal morphine groups to assess postoperative pain scores and patient satisfaction. Patients will also be assessed for side effects from the intervention.
Interventions
- DRUG Placebo
- DRUG Intrathecal morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2018-06-19 |
| Est. Completion | 2020-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03241485
The ClinicalTrials.gov registry entry for NCT03241485 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03241485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03241485 about?
NCT03241485 is a clinical study titled "Trial Comparing Intrathecal Morphine With Placebo In Patients Undergoing Robotic Cardiac Surgery". This is a randomized clinical trial in patients undergoing robotic myocardial revascularization with intraoperative extubation. Patients will be randomized into placebo or intrathecal morphine groups to assess postoperative pain scores and patient satisfaction. Patients will also be assessed for sid...
What is the current status of trial NCT03241485?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 79 participants. The study started on 2018-06-19. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT03241485?
The interventions under investigation include: Placebo (DRUG), Intrathecal morphine (DRUG).
Who is sponsoring clinical trial NCT03241485?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.